相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prognostic and Predictive Biomarkers in Patients With Coronavirus Disease 2019 Treated With Tocilizumab in a Randomized Controlled Trial*
Jennifer Tom et al.
CRITICAL CARE MEDICINE (2022)
A systematic review of subgroup analyses in randomised clinical trials in cardiovascular disease
Korbinian J. Brand et al.
CLINICAL TRIALS (2021)
Encouragement of subgroup assessment by the FDA
Robert Temple
PHARMACEUTICAL STATISTICS (2021)
Recent Advances in Systemic Treatments for HER-2 Positive Advanced Gastric Cancer
Seda Kahraman et al.
ONCOTARGETS AND THERAPY (2021)
Ketamine as an antidepressant: overview of its mechanisms of action and potential predictive biomarkers
Dmitriy Matveychuk et al.
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2020)
Liposomal irinotecan and 5-fluorouracil/leucovorin in older patients with metastatic pancreatic cancer - A subgroup analysis of the pivotal NAPOLI-1 trial
Teresa Macarulla et al.
JOURNAL OF GERIATRIC ONCOLOGY (2019)
Rituximab maintenance overcomes the negative prognostic factor of obesity in CLL: Subgroup analysis of the international randomized AGMT CLL-8a mabtenance trial
Alexander Egle et al.
CANCER MEDICINE (2019)
Justification and reporting of subgroup analyses were lacking or inadequate in randomized controlled trials
Jingchun Fan et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2019)
Guidance from key organisations on exploring, confirming and interpreting subgroup effects of medical treatments: a scoping review
Stan R. W. Wijn et al.
BMJ OPEN (2019)
Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with ST-segment elevation myocardial infarction (BIOSTEMI): a single-blind, prospective, randomised superiority trial
Juan F. Iglesias et al.
LANCET (2019)
Identifying Which Urban Children With Asthma Benefit Most From Clinician Prompting: Subgroup Analyses From the Prompting Asthma Intervention in Rochester-Uniting Parents and Providers (PAIR-UP) Trial
Nicolas P. N. Goldstein et al.
ACADEMIC PEDIATRICS (2018)
Mortality Benefit of Recombinant Human Interleukin-1 Receptor Antagonist for Sepsis Varies by Initial Interleukin-1 Receptor Antagonist Plasma Concentration
Nuala J. Meyer et al.
CRITICAL CARE MEDICINE (2018)
Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children
A. Drilon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Efficacy and safety of benralizumab in Japanese patients with severe, uncontrolled eosinophilic asthma
Ken Ohta et al.
ALLERGOLOGY INTERNATIONAL (2018)
A Randomized Controlled Trial to Evaluate the Safety and Efficacy of Cardiac Contractility Modulation
William T. Abraham et al.
JACC-HEART FAILURE (2018)
Effect of Adding Motolimod to Standard Combination Chemotherapy and Cetuximab Treatment of Patients With Squamous Cell Carcinoma of the Head and Neck The Active8 Randomized Clinical Trial
Robert L. Ferris et al.
JAMA ONCOLOGY (2018)
Tutorial in biostatistics: data-driven subgroup identification and analysis in clinical trials
Ilya Lipkovich et al.
STATISTICS IN MEDICINE (2017)
Repetitive transcranial magnetic stimulation improves cognitive function of Alzheimer's disease patients
Junwu Zhao et al.
ONCOTARGET (2017)
Subgroup analysis and interaction tests: why they are important and how to avoid common mistakes
Juliana Carvalho Ferreira et al.
JORNAL BRASILEIRO DE PNEUMOLOGIA (2017)
Comparison of 2 Lumbar Manual Therapies on Temporal Summation of Pain in Healthy Volunteers
Charles W. Penza et al.
JOURNAL OF PAIN (2017)
Web-based self-management support for people with type 2 diabetes (HeLP-Diabetes): randomised controlled trial in English primary care
Elizabeth Murray et al.
BMJ OPEN (2017)
Readiness to change and therapy outcomes of an innovative psychotherapy program for surgical patients: results from a randomized controlled trial
Henning Krampe et al.
BMC PSYCHIATRY (2017)
Predictive and prognostic factors associated with soft tissue sarcoma response to chemotherapy: a subgroup analysis of the European Organisation for Research and Treatment of Cancer 62012 study
Robin J. Young et al.
ACTA ONCOLOGICA (2017)
Overall survival of first-line axitinib in metastatic renal cell carcinoma: Japanese subgroup analysis from phase II study
Mototsugu Oya et al.
CANCER SCIENCE (2017)
Efficacy and safety of enzalutamide in patients 75 years or older with chemotherapy-naive metastatic castration-resistant prostate cancer: results from PREVAIL
J. N. Graff et al.
ANNALS OF ONCOLOGY (2016)
General guidance on exploratory and confirmatory subgroup analysis in late-stage clinical trials
Alex Dmitrienko et al.
JOURNAL OF BIOPHARMACEUTICAL STATISTICS (2016)
Subgroup analyses in confirmatory clinical trials: time to be specific about their purposes
Julien Tanniou et al.
BMC MEDICAL RESEARCH METHODOLOGY (2016)
Cumulative subgroup analysis to reduce waste in clinical research for individualised medicine
F. J. Song et al.
BMC MEDICINE (2016)
Realizing the Full Potential of Precision Medicine in Health and Health Care
Victor J. Dzau et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Patient characteristics associated with greater blood pressure control in a randomized trial of home blood pressure telemonitoring and pharmacist management
Stephen E. Asche et al.
JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION (2016)
Uncertainty in the Era of Precision Medicine
David J. Hunter
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Postoperative Care Navigation for Total Knee Arthroplasty Patients: A Randomized Controlled Trial
Elena Losina et al.
ARTHRITIS CARE & RESEARCH (2016)
Three simple rules to ensure reasonably credible subgroup analyses
James F. Burke et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Three simple rules to ensure reasonably credible subgroup analyses
James F. Burke et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
How to Use a Subgroup Analysis
Xin Sun et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Credibility of claims of subgroup effects in randomised controlled trials: systematic review
Xin Sun et al.
BMJ-BRITISH MEDICAL JOURNAL (2012)
A note on dichotomization of continuous response variable in the presence of contamination and model misspecification
Yue Shentu et al.
STATISTICS IN MEDICINE (2010)
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
Kenneth F. Schulz et al.
TRIALS (2010)
Statistics in medicine - Reporting of subgroup analyses in clinical trials
Rui Wang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Estimation of the Youden index and its associated cutoff point
R Fluss et al.
BIOMETRICAL JOURNAL (2005)
Treating Individuals 2 - Subgroup analysis in randomised controlled trials: importance, indications, and interpretation
PM Rothwell
LANCET (2005)
Inflation of the type I error rate when a continuous confounding variable is categorized in logistic regression analyses
PC Austin et al.
STATISTICS IN MEDICINE (2004)
The impact of dichotomization on the efficiency of testing for an interaction effect in exponential family models
VT Farewell et al.
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION (2004)
A new approach to modelling interactions between treatment and continuous covariates in clinical trials by using fractional polynomials
P Royston et al.
STATISTICS IN MEDICINE (2004)
How do risk factors work together? Mediators, moderators, and independent, overlapping, and proxy risk factors
HC Kraemer et al.
AMERICAN JOURNAL OF PSYCHIATRY (2001)
分享论文
